More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$14.85B
EPS
15.89
P/E ratio
26.3
Price to sales
4.46
Dividend yield
--
Beta
1.185245
Previous close
$512.79
Today's open
$517.87
Day's range
$512.55 - $533.09
52 week range
$305.69 - $628.92
show more
CEO
August J. Troendle
Employees
6200
Headquarters
Cincinnati, OH
Exchange
Nasdaq Global Select
Shares outstanding
28559689
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
Medpace (MEDP) Advances While Market Declines: Some Information for Investors
Medpace (MEDP) reached $519.96 at the closing of the latest trading day, reflecting a +1.4% change compared to its last close.
Zacks Investment Research • Jun 25, 2026

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday, July 23, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you joi.
Business Wire • Jun 16, 2026

Medpace (MEDP) Suffers a Larger Drop Than the General Market: Key Insights
Medpace (MEDP) closed the most recent trading day at $461.6, moving 1.26% from the previous trading session.
Zacks Investment Research • Jun 16, 2026

CON vs. MEDP: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Services sector might want to consider either Concentra Group (CON) or Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
Zacks Investment Research • Jun 12, 2026

Why the Market Dipped But Medpace (MEDP) Gained Today
Medpace (MEDP) closed at $466.79 in the latest trading session, marking a +1.94% move from the prior day.
Zacks Investment Research • Jun 9, 2026

MEDP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026
NEW YORK--(BUSINESS WIRE)---- $MEDP #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The fir.
Business Wire • Jun 8, 2026

Safirstein Law LLC Announces That A Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP)
RIDGEWOOD, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- RIDGEWOOD, N.J., June 8, 2026 (GLOBE NEWSWIRE) -- Safirstein Law LLC announces that a class action lawsuit has been filed on behalf of shareholders against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:MEDP).
GlobeNewsWire • Jun 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, June 8, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Medpace securities between April 22, 2025 and February 9, 2026, both dates inclusive (the "Class Period").
PRNewsWire • Jun 8, 2026

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Highlights Class Action Against Medpace Holdings (MEDP) and Upcoming Lead Plaintiff Deadline of June 8, 2026
NEW YORK--(BUSINESS WIRE)---- $MEDP #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The fir.
Business Wire • Jun 8, 2026

INVESTOR DEADLINE: Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
San Diego, California--(Newsfile Corp. - June 8, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, all dates inclusive (the "Class Period"), have until today, Monday, June 8, 2026 to seek appointment as lead plaintiff of the Medpace class action lawsuit. Captioned Durbin v.
Newsfile Corp • Jun 8, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Medpace Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.